Parkinson's Disease
Conditions
Interventions
This is a two-arm, single-blind, randomized controlled clinical study. Intervention group: 10 people with Parkinson's disease, men and women, will be seen by the physical therapist 3 times a week thro
Sponsors
Bruno Lopes dos Santos Lobato
Universidade Federal do Pará
Eligibility
Age
30 Years to 80 Years
Inclusion criteria
Inclusion criteria: Patients diagnosed with idiopathic Parkinson's disease according to the London Brain Bank diagnostic criteria; Age between 30 and 80 years; Mild stage disease (Hoehn and Yahr equal to or less than 2); Use of pharmacological dopaminergic treatment at a stable dose for at least one month, with the possibility of remaining unchanged during the intervention period
Exclusion criteria
Exclusion criteria: Any type of atypical secondary parkinsonism; Treatment with any drug or experimental intervention in the last 90 days; Presence of severe psychotic symptoms (score greater than 2 in item 1.2 of the International Parkinson and Movement Disorders Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS); Diagnosis of dementia determined by the flowchart proposed by the Movement Disorders Society; Presence of severe systemic diseases or decompensated such as: infections, severe heart disease, malignant neoplasm, liver or kidney failure, poorly controlled diabetes; Presence of orthopedic diseases, other neurological diseases or cardiac comorbidities that prevent or pose a risk for performing aerobic or stretching exercises; Patients without access to internet at home; Patients who are unable to perform tasks on the computer, or without family assistance needed for remote activities
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Evaluate patients' adherence to interventions and the occurrence of adverse effects, such as safety measures, at the end of the fourth week of treatment in relation to the baseline evaluation | — |
Secondary
| Measure | Time frame |
|---|---|
| Improvements are expected in the scores of the International Parkinson and Movement Disorders Society- Unified Parkinson's Disease Rating Scale (MDS-UPDRS) and in the Hoehn and Yahr Staging (HY), a scale used to measure the severity of Parkinson's disease.;Assessment of gait and balance, through the Time Up and Go instrumented test.;It is expected to find improvement in the assessment scale of confidence in balance, 5 times Sit and Stand test, 6-minute walk test to assess physical capacity;;It is expected to see an improvement in the Montreal Cognitive Assessment (MoCA) for cognitive screening, a 15-item Geriatric Depression Scale for brief screening for the presence of depression, a scale that scores the response to interventions- Clinician's Global Impression of Change (CGI-C) , and in the questionnaire composed of 8 questions that assess aspects of the patient's quality of life - Parkinson's Disease Questionnaire (PDQ-8). | — |
Countries
Brazil
Contacts
Public ContactTamires Vilacorta Pereira
Universidade Federal do Pará
Outcome results
None listed